Spots Global Cancer Trial Database for Evaluation of Pancreatic Steatosis in Patients With Cancer of Pancreas
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Evaluation of Pancreatic Steatosis in Patients With Cancer of Pancreas
Official Title: Prognostic Importance of Quantitative Magnetic Resonance Imaging for Evaluation of Pancreatic Steatosis in Patients With Pancreatic Cancer
Study ID: NCT02682394
Conditions
Interventions
Study Description
Brief Summary: Prognostic Importance of Quantitative Magnetic Resonance Imaging for Evaluation of Pancreatic Steatosis in Patients with Pancreatic Cancer
Detailed Description: 1. Finding patients with pancreatic cancer (in all stages), before any treatment. 2. Non invasively quantify fatty infiltration of pancreas using, MRI DIXON Scan in pancreatic cancer patient relatively to liver. 3. Measuring cell-free blood DNA in those patients for evaluating the aggressiveness of the disease. 4. Quantify the prognostic significance of pancreatic steatosis in comparison with clinical and pathological prognostic indexes used today.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Soroka university medical center, Beer Sheva, , Israel
Contact Details
Name: Alla Khashper, MD
Affiliation: Soroka University Medical Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
